Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach

Digestive Diseases and Sciences

Volumn 60, Issue 6, 2015, Pages 1522-1527

  Waldum, Helge L ^a,b   Hauso, Øyvind ^a,b   Sørdal, Øystein F ^a,b   Fossmark, Reidar ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Carcinogenesis; Gastric acid secretion; Gastric cancer; Gastrin; Gastritis; Helicobacter pylori

Indexed keywords

GASTRIN;

ATROPHIC GASTRITIS; CARCINOGENESIS; ENTEROCHROMAFFIN LIKE CELL; GASTRIC HYPOACIDITY; HELICOBACTER INFECTION; HUMAN; HYPERGASTRINEMIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH PH; ANIMAL; GASTRITIS; HELICOBACTER PYLORI; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PH; PHYSIOLOGY; RISK; STOMACH MUCOSA; STOMACH TUMOR;

ANIMALS; GASTRIC MUCOSA; GASTRINS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; RISK; STOMACH NEOPLASMS;

EID: 84930379684     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3468-9     Document Type: Review

References (92)

1. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003;56:1–9.
2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150.
3. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.
4. Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev. 2009;18:1945–1952.
5. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402–405.
6. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–1131.
7. Siurala M, Isokoski M, Varis K, Kekki M. Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random. Scand J Gastroenterol. 1968;3:211–223.
8. Konjetzny GE. Über d. besichungen d. chronischen Gastritis mit ihren folgeerscheinungen und d. chronischen magenulcus zur entwicklung des magenkrebses. Beit Klin Chir. 1913;85:455.
9. Morson BC. Intestinal metaplasia of the gastric mucosa. Br J Cancer. 1955;9:365–376.
10. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–1315.
11. Levi S, Beardshall K, Haddad G, et al. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet. 1989;1:1167–1168.
12. Hansson LE, Nyren O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335:242–249.
13. Ubukata H, Nagata H, Tabuchi T, et al. Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer. Gastric Cancer. 2011;14:4–12.
14. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–789.
15. Testoni PA, Masci E, Marchi R, et al. Gastric cancer in chronic atrophic gastritis. Associated gastric ulcer adds no further risk. J Clin Gastroenterol. 1987;9:298–302.
16. Chuang CH, Sheu BS, Yang HB, et al. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa. J Gastroenterol Hepatol. 2004;19:988–993.
17. Walker IR, Strickland RG, Ungar B, Mackay IR. Simple atrophic gastritis and gastric carcinoma. Gut. 1971;12:906–911.
18. Tatsuta M, Iishi H, Nakaizumi A, et al. Fundal atrophic gastritis as a risk factor for gastric cancer. Int J Cancer. 1993;53:70–74.
19. Roland JT, Choi E, Barlow BJ, et al. Geographic mapping of the cell lineages within the human stomach reveals regional concentrations of enteroendocrine cells and parietal cells throughout the antrum. DDW Abstract Orlando. 2013: A-10.
20. Kokkola A, Sjoblom SM, Haapiainen R, et al. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol. 1998;33:88–92.
21. Stockbrugger RW, Menon GG, Beilby JO, Mason RR, Cotton PB. Gastroscopic screening in 80 patients with pernicious anaemia. Gut. 1983;24:1141–1147.
22. Arnold IC, Lee JY, Amieva MR, et al. Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology. 2011;140:199–209.
23. Hatakeyama M. Helicobacter pylori CagA—a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer. 2006;119:1217–1223.
24. Noto JM, Piazuelo MB, Chaturvedi R, et al. Strain-specific suppression of microRNA-320 by carcinogenic Helicobacter pylori promotes expression of the antiapoptotic protein Mcl-1. Am J Physiol Gastrointest Liver Physiol. 2013;305:G786–G796.
25. Wei J, Noto JM, Zaika E, et al. Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner. Gut. 2014. doi:10.1136/gutjnl-2014-307295.
26. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330:1267–1271.
27. Waldum HL, Sandvik AK, Brenna E, Petersen H. Gastrin-histamine sequence in the regulation of gastric acid secretion. Gut. 1991;32:698–701.
28. Marshall BJ, Langton SR. Urea hydrolysis in patients with Campylobacter pyloridis infection. Lancet. 1986;1:965–966.
29. Sandvik AK, Waldum HL. Rat gastric histamine release: a sensitive gastrin bioassay. Life Sci. 1990;46:453–459.
30. Waldum HL, Arnestad JS, Brenna E, et al. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut. 1996;39:649–653.
31. Stadil F, Rehfeld JF. Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scand J Gastroenterol. 1973;8:101–112.
32. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 1997;113:15–24.
33. Korman MG, Strickland RG, Hansky J. Serum gastrin in chronic gastritis. Br Med J. 1971;2:16–18.
34. Stockbrugger R, Larsson LI, Lundqvist G, Angervall L. Antral gastrin cells and serum gastrin in achlorhydria. Scand J Gastroenterol. 1977;12:209–213.
35. Gedde-Dahl D. Fasting serum gastrin levels in humans with low pentagastrin-stimulated gastric acid secretion. Scand J Gastroenterol. 1974;9:597–599.
36. Zhao CM, Wang X, Friis-Hansen L, et al. Chronic Helicobacter pylori infection results in gastric hypoacidity and hypergastrinemia in wild-type mice but vagally induced hypersecretion in gastrin-deficient mice. Regul Pept. 2003;115:161–170.
37. Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol. 2005;96:94–102.
38. Mirvish SS. The etiology of gastric cancer. Intragastric nitrosamide formation and other theories. J Natl Cancer Inst. 1983;71:629–647.
39. Zamcheck N, Grable E, Ley A, Norman L. Occurrence of gastric cancer among patients with pernicious anemia at the Boston City Hospital. N Engl J Med. 1955;252:1103–1110.
40. Qvigstad G, Qvigstad T, Westre B, et al. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia. APMIS. 2002;110:132–139.
41. Ryberg B, Tielemans Y, Axelson J, et al. Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology. 1990;99:935–942.
42. Creutzfeldt W, Lamberts R, Stockmann F, Brunner G. Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole. Scand J Gastroenterol Suppl. 1989;166:122–128; discussion 138-129.
43. Bakke I, Qvigstad G, Brenna E, Sandvik AK, Waldum HL. Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation. Acta Physiol Scand. 2000;169:29–37.
44. Bakke I, Qvigstad G, Sandvik AK, Waldum HL. The CCK-2 receptor is located on the ECL cell, but not on the parietal cell. Scand J Gastroenterol. 2001;36:1128–1133.
45. Waldum HL, Sandvik AK, Brenna E. Gastrin: Histamine-releasing activity. In: Walsh JH, ed. Gastrin. New York: Raven Press; 1993:259–271.
46. Athmann C, Zeng N, Scott DR, Sachs G. Regulation of parietal cell calcium signaling in gastric glands. Am J Physiol Gastrointest Liver Physiol. 2000;279:G1048–G1058.
47. Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg. 1955;142:709–723; discussion, 724–708.
48. Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion. 1986;35:42–55.
49. Poynter D, Selway SA, Papworth SA, Riches SR. Changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine H2 blockade. Gut. 1986;27:1338–1346.
50. Nilsson O, Wangberg B, Johansson L, et al. Rapid induction of enterochromaffinlike cell tumors by histamine2-receptor blockade. Am J Pathol. 1993;142:1173–1185.
51. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology. 1998;115:642–648.
52. Waldum HL, Rorvik H, Falkmer S, Kawase S. Neuroendocrine (ECL cell) differentiation of spontaneous gastric carcinomas of cotton rats (Sigmodon hispidus). Lab Anim Sci. 1999;49:241–247.
53. Borch K, Renvall H, Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology. 1985;88:638–648.
54. Feurle GE. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome. Gut. 1994;35:275–277.
55. Jianu CS, Fossmark R, Viset T, et al. Gastric carcinoids after long-term use of a proton pump inhibitor. Alim Pharmacol Ther. 2012;36:644–649.
56. Poynter D. Long-term effects of reduced gastric acidity in laboratory animals. Digestion. 1985;31:174.
57. Soga J, Tazawa K, Kanahara H, Hiraide K. Some characteristic features of spontaneous argyrophil cell carcinoids in glandular stomach of Praomys (mastomys) natalensis. GANN Monogr. 1969;8:15–26.
58. Brenna E, Waldum HL. Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: establishment of a dose response relationship. Gut. 1992;33:1303–1306.
59. Kleveland PM, Waldum HL, Larsson H. Gastric acid secretion in the totally isolated, vascularly perfused rat stomach. A selective muscarinic-1 agent does, whereas gastrin does not, augment maximal histamine-stimulated acid secretion. Scand J Gastroenterol. 1987;22:705–713.
60. Blair AJ 3rd, Richardson CT, Walsh JH, Feldman M. Variable contribution of gastrin to gastric acid secretion after a meal in humans. Gastroenterology. 1987;92:944–949.
61. Sjoblom SM, Sipponen P, Karonen SL, Järvinen HJ. Argyrophil cell hyperplasia and carcinoid tumours in oxyntic mucosa of the stomach. Dependence on duration of pernicious anaemia. Eur J Gastroenerol Hepatol. 1991;31:153–157.
62. Waldum HL, Haugen OA, Isaksen C, Mecsei R, Sandvik AK. Are diffuse gastric carcinomas neuroendocrine tumours? (ECL-omas). Eur J Gastroenterol Hepatol. 1991;3:245–249.
63. Waldum HL, Aase S, Kvetnoi I, et al. Neuroendocrine differentiation in human gastric carcinoma. Cancer. 1998;83:435–444.
64. Qvigstad G, Falkmer S, Westre B, Waldum HL. Clinical and histopathological tumour progression in ECL cell carcinoids (“ECLomas”). APMIS. 1999;107:1085–1092.
65. Qvigstad G, Sandvik AK, Brenna E, Aase S, Waldum HL. Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique. Histochem J. 2000;32:551–556.
66. Sordal O, Qvigstad G, Nordrum IS, Waldum HL. Evaluation of mucin and neuroendocrine expression in diffuse gastric cancer with signet ring cell morphology. DDW Abstract. 2013;A-1346.
67. Bakkelund K, Fossmark R, Nordrum I, Waldum H. Signet ring cells in gastric carcinomas are derived from neuroendocrine cells. J Histochem Cytochem. 2006;54:615–621.
68. Sordal O, Qvigstad G, Nordrum IS, Gustafsson B, Waldum HL. In situ hybridization in human and rodent tissue by the use of a new and simplified method. Appl Immunohisthochem Mol Morphol. 2012;2:185–189.
69. Fujiyoshi Y, Eimoto T. Chromogranin A expression correlates with tumour cell type and prognosis in signet ring cell carcinoma of the stomach. Histopathology. 2008;52:305–313.
70. Bartley AN, Rashid A, Fournier KF, Abraham SC. Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: evidence for a common cell of origin in composite tumors. Hum Pathol. 2011;42:1420–1429.
71. Sundler F, Hakanson R (1991) Gastric endocrine cell typing at the light microscopic level. The stomach as an endocrine organ, R Håkanson F Sundler (Eds): 9-20.
72. Sato Y, Iwafuchi M, Ueki J, et al. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection. Dig Dis Sci. 2002;47:579–585.
73. Guilford PJ, Hopkins JB, Grady WM, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat. 1999;14:249–255.
74. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994;54:3845–3852.
75. Blok P, Craanen ME, Dekker W, Tytgat GN. Loss of E-cadherin expression in early gastric cancer. Histopathology. 1999;34:410–415.
76. Waldum HL, Ringnes E, Nordbo H, et al. The normal neuroendocrine cells of the upper gastrointestinal tract lack E-cadherin. Scand J Gastroenterol. 2014.
77. Sekikawa A, Fukui H, Fujii S, et al. REG Ialpha protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology. 2005;128:642–653.
78. Waldum HL, Sandvik AK, Brenna E. Gastrin, the enterochromaffinlike cell, and gastric tumors. Gastroenterology. 1993;105:1264–1266.
79. McGuigan JE, Trudeau WL. Serum and tissue gastrin concentrations in patients with carcinoma of the stomach. Gastroenterology. 1973;64:22–25.
80. Fossmark R, Sagatun L, Sandvik AK, Nordrum IS, Waldum H. Serum gastrin in relation to tumor localization, histological classification and survival in patients with non-cardia adenocarcinomas in the stomach. DDW Abstract Book SA. 2014;1873:541.
81. Kumamoto T. Gastrin receptors in human gastric scirrhous carcinoma. Gastroenterol Jpn. 1988;23:384–389.
82. Yoshida T, Kato J, Inoue I, et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer. 2014;134:1445–1457.
83. Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 2000;118:36–47.
84. Peek RM Jr, Wirth HP, Moss SF, et al. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology. 2000;118:48–59.
85. Cui G, Qvigstad G, Falkmer S, et al. Spontaneous ECLomas in cotton rats (Sigmodon hispidus): tumours occurring in hypoacidic/hypergastrinaemic animals with normal parietal cells. Carcinogenesis. 2000;21:23–27.
86. Martinsen TC, Kawase S, Hakanson R, et al. Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist. Carcinogenesis. 2003;24:1887–1896.
87. Pritchard DM, Przemeck SM. Review article: How useful are the rodent animal models of gastric adenocarcinoma? Alim Pharmacol Ther. 2004;19:841–859.
88. Sordal O, Waldum H, Nordrum IS, et al. The gastrin receptor antagonist netazepide (YF476) prevents oxyntic mucosal inflammation induced by Helicobacter pylori infection in Mongolian gerbils. Helicobacter. 2013;18:397–405.
89. Takaishi S, Cui G, Frederick DM, et al. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology. 2005;128:1965–1983.
90. Burkitt MD, Varro A, Pritchard DM. Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol. 2009;15:1–16.
91. Waldum HL, Pettersen H, Brenna E. Gastrin and gastric cancer. Eur J Gastroenterol Hepatol. 1992;4:801–811.
92. The Cancer Genome Atlas Research N, Analysis Working Group: Dana-Farber Cancer I, Institute for Systems B, University of Southern C, Memorial Sloan Kettering Cancer C, et al. (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature.